文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Edaravone (Radicava) for ALS.

出版信息

Med Lett Drugs Ther. 2017 Nov 6;59(1533):180-182.

DOI:
PMID:29125592
Abstract
摘要

相似文献

[1]
Edaravone (Radicava) for ALS.

Med Lett Drugs Ther. 2017-11-6

[2]
Edaravone in ALS.

Exp Neurol. 2009-6

[3]
Edaravone: a new hope for deadly amyotrophic lateral sclerosis.

Drugs Today (Barc). 2018-6

[4]
Edaravone and its clinical development for amyotrophic lateral sclerosis.

Amyotroph Lateral Scler Frontotemporal Degener. 2017-10

[5]
A safety analysis of edaravone (MCI-186) during the first six cycles (24 weeks) of amyotrophic lateral sclerosis (ALS) therapy from the double-blind period in three randomized, placebo-controlled studies.

Amyotroph Lateral Scler Frontotemporal Degener. 2017-10

[6]
Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis.

Amyotroph Lateral Scler Frontotemporal Degener. 2017-10

[7]
Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration.

Redox Rep. 2016-5

[8]
Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation).

Amyotroph Lateral Scler Frontotemporal Degener. 2017-10

[9]
July 2017 ENCALS statement on edaravone.

Amyotroph Lateral Scler Frontotemporal Degener. 2017-11

[10]
Exploratory double-blind, parallel-group, placebo-controlled extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis.

Amyotroph Lateral Scler Frontotemporal Degener. 2017-10

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索